JP2025160175A5 - - Google Patents

Info

Publication number
JP2025160175A5
JP2025160175A5 JP2025107301A JP2025107301A JP2025160175A5 JP 2025160175 A5 JP2025160175 A5 JP 2025160175A5 JP 2025107301 A JP2025107301 A JP 2025107301A JP 2025107301 A JP2025107301 A JP 2025107301A JP 2025160175 A5 JP2025160175 A5 JP 2025160175A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
independently selected
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025107301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025160175A (ja
Filing date
Publication date
Priority claimed from PCT/US2022/014221 external-priority patent/WO2022165114A1/en
Application filed filed Critical
Publication of JP2025160175A publication Critical patent/JP2025160175A/ja
Publication of JP2025160175A5 publication Critical patent/JP2025160175A5/ja
Pending legal-status Critical Current

Links

JP2025107301A 2021-01-29 2025-06-25 Cd38阻害剤としてのキノリン及びアザキノリン Pending JP2025160175A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163143245P 2021-01-29 2021-01-29
US63/143,245 2021-01-29
PCT/US2022/014221 WO2022165114A1 (en) 2021-01-29 2022-01-28 Quinolines and azaquinolines as inhibitors of cd38
JP2023544674A JP7777596B2 (ja) 2021-01-29 2022-01-28 Cd38阻害剤としてのキノリン及びアザキノリン

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023544674A Division JP7777596B2 (ja) 2021-01-29 2022-01-28 Cd38阻害剤としてのキノリン及びアザキノリン

Publications (2)

Publication Number Publication Date
JP2025160175A JP2025160175A (ja) 2025-10-22
JP2025160175A5 true JP2025160175A5 (cg-RX-API-DMAC7.html) 2026-03-13

Family

ID=80446310

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023544674A Active JP7777596B2 (ja) 2021-01-29 2022-01-28 Cd38阻害剤としてのキノリン及びアザキノリン
JP2025107301A Pending JP2025160175A (ja) 2021-01-29 2025-06-25 Cd38阻害剤としてのキノリン及びアザキノリン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2023544674A Active JP7777596B2 (ja) 2021-01-29 2022-01-28 Cd38阻害剤としてのキノリン及びアザキノリン

Country Status (25)

Country Link
US (2) US11952377B2 (cg-RX-API-DMAC7.html)
EP (2) EP4674415A3 (cg-RX-API-DMAC7.html)
JP (2) JP7777596B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230141799A (cg-RX-API-DMAC7.html)
CN (1) CN117580829A (cg-RX-API-DMAC7.html)
AR (1) AR124718A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022212035A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023014898A2 (cg-RX-API-DMAC7.html)
CA (1) CA3208851A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023002163A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023009803A2 (cg-RX-API-DMAC7.html)
CR (1) CR20230323A (cg-RX-API-DMAC7.html)
DO (1) DOP2023000142A (cg-RX-API-DMAC7.html)
EC (1) ECSP23056223A (cg-RX-API-DMAC7.html)
ES (1) ES3042412T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20251111T1 (cg-RX-API-DMAC7.html)
HU (1) HUE072981T2 (cg-RX-API-DMAC7.html)
IL (1) IL304466A (cg-RX-API-DMAC7.html)
JO (1) JOP20230160A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023008701A (cg-RX-API-DMAC7.html)
PE (1) PE20232047A1 (cg-RX-API-DMAC7.html)
PL (1) PL4284511T3 (cg-RX-API-DMAC7.html)
RS (1) RS67253B1 (cg-RX-API-DMAC7.html)
TW (1) TW202241418A (cg-RX-API-DMAC7.html)
WO (1) WO2022165114A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11535621B2 (en) 2019-07-31 2022-12-27 Ribon Therapeutics, Inc. Heterobicyclic amides as inhibitors of CD38
EP4263524A1 (en) 2020-12-21 2023-10-25 Cytokinetics, Inc. Pyrazole derivatives useful as nampt modulators
CN117715897A (zh) 2021-04-30 2024-03-15 南京艾美斐生物医药科技有限公司 化合物及其作为cd38抑制剂的用途
WO2024217995A1 (en) 2023-04-20 2024-10-24 Syngenta Crop Protection Ag Pesticidally active dihydropyridinone derivatives
WO2026000074A1 (en) * 2024-06-25 2026-01-02 Welnx Company Inc. Use of cd38 inhibitors for reducing th2 inflammation
WO2026075971A1 (en) 2024-10-01 2026-04-09 Neolaia Inc. Combination therapy for treatment of metabolic disorders and inflamation related disorders using incretin compounds and cd38 inhibitors
WO2026143058A1 (en) * 2024-12-23 2026-07-02 Neolaia Inc. Pyridopyrimidine compounds useful as cd38 inhibitors
WO2026143049A1 (en) * 2024-12-23 2026-07-02 Neolaia Inc. Aminoquinolinones useful as cd38 inhibitors
CN119775288B (zh) * 2024-12-31 2025-10-10 浙江工业大学 一种cd38抑制化合物及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2646020B1 (en) 2010-12-01 2016-09-21 Glaxosmithkline LLC Indoles
AU2012332297B2 (en) 2011-11-04 2016-01-07 Glaxosmithkline Intellectual Property (No.2) Limited Method of treatment
EA201591746A1 (ru) 2013-03-14 2016-08-31 КОНВЕРДЖЕН ЭлЭлСи Способы и композиции для ингибирования бромодомен-содержащих белков
CN107428733A (zh) 2014-12-03 2017-12-01 葛兰素史克知识产权第二有限公司 Cd38抑制剂和治疗方法
WO2017053604A1 (en) 2015-09-23 2017-03-30 The Regents Of The University Of California Potent antiviral pyrazolopyridine compounds
WO2018151830A1 (en) 2017-02-17 2018-08-23 Fronthera U.S. Pharmaceuticals Llc Pyridinyl based apoptosis signal-regulation kinase inhibitors
EP3434692A1 (en) 2017-07-24 2019-01-30 Encefa Compounds which specifically binds to cd38 for use in the treatment of neurodegenerative diseases
US11535621B2 (en) 2019-07-31 2022-12-27 Ribon Therapeutics, Inc. Heterobicyclic amides as inhibitors of CD38
US20230025807A1 (en) 2019-10-30 2023-01-26 Mitobridge Inc. Cd38 inhibitors
KR20230051425A (ko) 2020-04-07 2023-04-18 미토브리지, 인크. Cd38 억제제

Similar Documents

Publication Publication Date Title
RU2573834C2 (ru) ФАРМАЦЕВТИЧЕСКИ АКТИВНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Axl
KR101709492B1 (ko) 신규한 소염제
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP5261575B2 (ja) 化学化合物
JP2023501253A5 (cg-RX-API-DMAC7.html)
JP6231085B2 (ja) アミノキナゾリン誘導体及びピリドピリミジン誘導体
JP2010513304A5 (cg-RX-API-DMAC7.html)
JP2010529991A5 (cg-RX-API-DMAC7.html)
ES2423851T3 (es) Compuesto de aciltiourea o sal del mismo y uso del mismo
JP2022542396A5 (cg-RX-API-DMAC7.html)
JP7158393B2 (ja) 環状構造を有する化合物
RU2008135690A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
JP2015533782A (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
RU2003131693A (ru) Новые ингибиторы тирозин киназ
JP2020503299A5 (cg-RX-API-DMAC7.html)
JPH07503017A (ja) イミダゾール誘導体およびそのサイトカイン阻害剤としての使用
JP2011515462A5 (cg-RX-API-DMAC7.html)
JP2009526072A5 (cg-RX-API-DMAC7.html)
JP2005538955A5 (cg-RX-API-DMAC7.html)
RU2008143457A (ru) Производные-2-пиразинона для лечения заболевания или состояния, при которых полезно ингибирование активности нейтрофильной эластазы
JP2022551422A5 (cg-RX-API-DMAC7.html)
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2017502057A (ja) ブロモドメイン阻害剤としての二環式複素環誘導体
HRP20251111T1 (hr) Azakinolini kao inhibitori cd38
JP2009525978A5 (cg-RX-API-DMAC7.html)